See also
  1. Smart Pills for Psychosis: The Tricky Ethical Challenges of Digital Medicine for Serious Mental Illness.Anna K. Swartz - 2018 - American Journal of Bioethics 18 (9):65-67.
  2. The First Smart Pill: Digital Revolution or Last Gasp?Anna K. Swartz & Phoebe Friesen - 2023 - Kennedy Institute of Ethics Journal 33 (3):277-319.
    ABSTRACT: Abilify MyCite was granted regulatory approval in 2017, becoming the world’s first “smart pill” that could digitally track whether patients had taken their medication. The new technology was introduced as one that had gained the support of patients and ethicists alike, and could contribute to solving the widespread and costly problem of patient nonadherence. Here, we offer an in-depth exploration of this narrative, through an examination of the origins and development of Abilify, the drug that would later become MyCite. (...)
    Direct download (3 more)  
    Export citation  
  3. A Feminist Bioethics Approach to Diagnostic Uncertainty.Anna K. Swartz - 2018 - American Journal of Bioethics 18 (5):37-39.